USA - NYSE:PHG - US5004723038
The current stock price of PHG is 28.17 USD. In the past month the price increased by 3.07%. In the past year, price increased by 5.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 69.98 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,263 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NVR- NY
High Tech Campus 5
Eindhoven NOORD-BRABANT 1096 BC NL
CEO: Frans van Houten
Employees: 67263
Phone: 31205977777
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,263 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The current stock price of PHG is 28.17 USD. The price decreased by -0.25% in the last trading session.
KONINKLIJKE PHILIPS NVR- NY (PHG) has a dividend yield of 3.97%. The yearly dividend amount is currently 0.
PHG has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The next ex-dividend date for KONINKLIJKE PHILIPS NVR- NY (PHG) is May 13, 2025.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PHG.
KONINKLIJKE PHILIPS NVR- NY (PHG) has a market capitalization of 27.13B USD. This makes PHG a Large Cap stock.
ChartMill assigns a technical rating of 7 / 10 to PHG. When comparing the yearly performance of all stocks, PHG turns out to be only a medium performer in the overall market: it outperformed 62.16% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to PHG. While PHG is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months PHG reported a non-GAAP Earnings per Share(EPS) of 1.67. The EPS increased by 12.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.91% | ||
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| Debt/Equity | 0.69 |
27 analysts have analysed PHG and the average price target is 31.77 USD. This implies a price increase of 12.77% is expected in the next year compared to the current price of 28.17.
For the next year, analysts expect an EPS growth of 0.24% and a revenue growth -1.93% for PHG